What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Rayjean J. Hung mainly investigates Cancer, Lung cancer, Internal medicine, Odds ratio and Genome-wide association study.
His Cancer research includes elements of Plasma cell, Cancer research, DNA methylation, Gene and Risk factor.
His Lung cancer study integrates concerns from other disciplines, such as Respiratory disease, Polymorphism, Immunology, Lung cancer susceptibility and Adenocarcinoma.
His work deals with themes such as Gastroenterology, Endocrinology and Pathology, which intersect with Internal medicine.
His Odds ratio research incorporates themes from Case-control study, Oncology, Genotype and Confidence interval.
His Genome-wide association study research integrates issues from CHEK2 and Bioinformatics.
His most cited work include:
- A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 (1074 citations)
- Lung cancer susceptibility locus at 5p15.33 (480 citations)
- Lung cancer susceptibility locus at 5p15.33 (480 citations)
What are the main themes of his work throughout his whole career to date?
Rayjean J. Hung focuses on Lung cancer, Internal medicine, Oncology, Cancer and Genome-wide association study.
His Lung cancer research is multidisciplinary, relying on both Genetics, Case-control study, Single-nucleotide polymorphism, Genetic association and Adenocarcinoma.
The study incorporates disciplines such as Genotype and Pathology in addition to Internal medicine.
His studies in Oncology integrate themes in fields like Body mass index, Carcinoma, Lung, Hazard ratio and Breast cancer.
His study in Cancer is interdisciplinary in nature, drawing from both Epidemiology and Risk factor.
Rayjean J. Hung has researched Genome-wide association study in several fields, including Disease, Genetic predisposition, Bioinformatics, Lung cancer susceptibility and Computational biology.
He most often published in these fields:
- Lung cancer (69.64%)
- Internal medicine (69.64%)
- Oncology (50.83%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (69.64%)
- Oncology (50.83%)
- Lung cancer (69.64%)
In recent papers he was focusing on the following fields of study:
Rayjean J. Hung spends much of his time researching Internal medicine, Oncology, Lung cancer, Genome-wide association study and Cancer.
His work on Incidence as part of general Internal medicine research is frequently linked to Mendelian randomization, bridging the gap between disciplines.
His studies deal with areas such as MEDLINE, Expression quantitative trait loci, Proportional hazards model, Hazard ratio and Risk factor as well as Oncology.
His Lung cancer research incorporates elements of Odds ratio, Body mass index, Lung, Lung cancer susceptibility and Adenocarcinoma.
The Genome-wide association study study combines topics in areas such as Genetic association and Genetic predisposition.
His Cancer study combines topics in areas such as Meta-analysis and Relative risk.
Between 2019 and 2021, his most popular works were:
- Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. (13 citations)
- Protein-altering germline mutations implicate novel genes related to lung cancer development. (5 citations)
- Transcriptome-wide association study reveals candidate causal genes for lung cancer (5 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary scientific interests are in Lung cancer, Internal medicine, Oncology, Genome-wide association study and Adenocarcinoma.
The concepts of his Lung cancer study are interwoven with issues in Lung cancer susceptibility, Observational study, Allele and MEDLINE.
His work on Hazard ratio, Cancer and Family history as part of general Internal medicine study is frequently linked to Mendelian randomization and Physical activity, bridging the gap between disciplines.
The various areas that Rayjean J. Hung examines in his Cancer study include Relative risk and Antibody.
His research integrates issues of Transcriptome, Obesity and Genetic association in his study of Genome-wide association study.
His research in Adenocarcinoma intersects with topics in Expression quantitative trait loci, Lung and Locus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
